It's a strange day when a tobacco company has far more success with its cigarette business than its reduced-risk products, but that's where Altria Group (NYSE: MO) finds itself today.
Altria just missed analyst revenue expectations in the second quarter while beating forecasts on earnings, but its investment in electronic-cigarette maker Juul Labs has been absolutely crushed by the Food and Drug Administration, which ordered its devices pulled from store shelves.
Image source: Getty Images.
Source Fool.com